FDA Investigator Timothy C Schell
Timothy C Schell has conducted inspections on 1 sites in 1 countries as of 12 Aug 2022. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
1
Last Inspection Date:
12 Aug 2022
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Timothy C Schell:
Amanda L Baskin,
Angel S Johnson,
Benjamin J Smith,
Brian D Garthwaite,
Byungja E Marciante,
Constantin Y Philopoulos,
Corrine M Carter,
David L Duncan,
Dr. Abhijit Raha, PhD,
Emest F Bizjak,
Etty Feller,
Jorge F Christian,
Joris Vanloco,
L'oreal F Walker,
Larry K Austin,
Leigh Anne Myers,
Lynda L Lanning,
Meisha R Sampson,
Meisha Waters,
Michael Y Philopoulos,
Patricia A Cochran,
Patricia H Dlugosz,
Ralph A Erickson,
Robert M Barbosa,
Sidney B Priesmeyer,
Susan P Bruederle
Timothy C Schell's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2002 | FDA 483 Response | Labcorp Drug Development Inc. - Form 483R, 2002-06-14 |
June, 2002 | EIR | Labcorp Drug Development Inc. - EIR, 2002-03-22 |
June, 2002 | FDA 483 | Labcorp Drug Development Inc. - Form 483, 2002-06-04 |
June, 2002 | FDA 483 | Labcorp Drug Development Inc. - Form 483, 2002-03-22 |
June, 2002 | EIR | Labcorp Drug Development Inc. - EIR, 2002-05-30 |
June, 2002 | FDA 483 Response | Labcorp Drug Development Inc. - Form 483R, 2002-06-14 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more